These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Inhibition of aldehyde reductase by aldose reductase inhibitors. Sato S, Kador PF. Biochem Pharmacol; 1990 Sep 01; 40(5):1033-42. PubMed ID: 2117925 [Abstract] [Full Text] [Related]
7. Purified rat lens aldose reductase. Polyol production in vitro and its inhibition by aldose reductase inhibitors. Kador PF, Kinoshita JH, Brittain DR, Mirrlees DJ, Sennitt CM, Stribling D. Biochem J; 1986 Nov 15; 240(1):233-7. PubMed ID: 3030278 [Abstract] [Full Text] [Related]
9. Intrinsic inhibition of aldose reductase. Kador PF, Sun G, Rait VK, Rodriguez L, Ma Y, Sugiyama K. J Ocul Pharmacol Ther; 2001 Aug 15; 17(4):373-81. PubMed ID: 11572468 [Abstract] [Full Text] [Related]
10. Polyol formation and NADPH-dependent reductases in dog retinal capillary pericytes and endothelial cells. Sato S, Secchi EF, Lizak MJ, Fukase S, Ohta N, Murata M, Tsai JY, Kador PF. Invest Ophthalmol Vis Sci; 1999 Mar 15; 40(3):697-704. PubMed ID: 10067973 [Abstract] [Full Text] [Related]
11. CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats. Peterson MJ, Sarges R, Aldinger CE, MacDonald DP. Metabolism; 1979 Apr 15; 28(4 Suppl 1):456-61. PubMed ID: 122297 [Abstract] [Full Text] [Related]
15. 3-FG as substrate for investigating flux through the polyol pathway in dog lens by 19F-NMR spectroscopy. Lizak MJ, Secchi EF, Lee JW, Sato S, Kubo E, Akagi Y, Kador PF. Invest Ophthalmol Vis Sci; 1998 Dec 15; 39(13):2688-95. PubMed ID: 9856779 [Abstract] [Full Text] [Related]
16. Novel spirosuccinimide aldose reductase inhibitors derived from isoquinoline-1,3-diones: 2-[(4-bromo-2-fluorophenyl)methyl]-6- fluorospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrone and congeners. 1. Malamas MS, Hohman TC, Millen J. J Med Chem; 1994 Jun 24; 37(13):2043-58. PubMed ID: 8027986 [Abstract] [Full Text] [Related]
17. Aldose reductase, a key enzyme in the oxidative deamination of norepinephrine in rats. Kawamura M, Eisenhofer G, Kopin IJ, Kador PF, Lee YS, Tsai JY, Fujisawa S, Lizak MJ, Sinz A, Sato S. Biochem Pharmacol; 1999 Aug 01; 58(3):517-24. PubMed ID: 10424772 [Abstract] [Full Text] [Related]
18. Determination of aldose reductase activity in the eye by localized magnetic resonance spectroscopy. Lizak MJ, Mori K, Kador PF. J Ocul Pharmacol Ther; 2001 Oct 01; 17(5):475-83. PubMed ID: 11765152 [Abstract] [Full Text] [Related]